Drugs / LV5FU2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04257461 | Feb 2020 → Dec 2025 | small intestine adenocarcinoma | Belgian Group of Digestive Oncology | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV5FU2 | “LV5FU2” NCT04257461 ↗ |